Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 23

Trial Status

Completed1
Terminated9

Role Distribution

Principal Investigator9
Other Roles1
PI Rate90%

Activity Timeline

Clinical Trials (10)

NCT00004058Phase 1Terminated
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Studychair
NCT00176475Phase 1Terminated
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Principalinvestigator
NCT00946283Not ApplicableTerminated
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Breast CancerChronic Myeloproliferative DisordersLeukemia+7 more
Principalinvestigator
NCT00996359Phase 1Terminated
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Principalinvestigator
NCT02105116Not ApplicableTerminated
AML Therapy With Irradiated Allogeneic Cells
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesCancer+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

CancerLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerOvary CancerCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Breast CancerCancer of KidneyOvary Cancer
Similarity Score3%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemiaNeuroblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Breast CancerLymphomaOvary Cancer
Similarity Score3%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

CancerLeukemia
Similarity Score2%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

LymphomaOvary Cancer
Similarity Score2%

Anjali Advani, MD

The Cleveland Clinic

Related
7 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Breast CancerCancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT00004058Phase 1StudyChair

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Terminated
NCT00156299Phase 1PrincipalInvestigator

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Leukemia
Terminated
NCT00161187Phase 1PrincipalInvestigator

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Cancer
Completed
NCT00176475Phase 1PrincipalInvestigator

Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease

LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Terminated
NCT00176501Phase 2PrincipalInvestigator

Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
Terminated
NCT00853125Phase 2PrincipalInvestigator

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
Terminated
NCT00946283Not ApplicablePrincipalInvestigator

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Breast CancerChronic Myeloproliferative DisordersLeukemia+7 more
Terminated
NCT00996359Phase 1PrincipalInvestigator

Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Terminated
NCT01009931Phase 2PrincipalInvestigator

Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies

Leukemia
Terminated
NCT02105116Not ApplicablePrincipalInvestigator

AML Therapy With Irradiated Allogeneic Cells

Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
Terminated

All 10 trials loaded